Similar articles for PMID: 21372112

Year	Number of Results
2000	1
2001	1
2002	2
2003	1
2004	3
2005	2
2006	4
2007	2
2008	8
2009	4
2010	5
2011	6
2012	4
2013	6
2014	9
2015	10
2016	8
2017	9
2018	8
2019	5
2020	5
2021	6
2022	0

1

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.

Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, Field AS, Boland J, Fabry Z. Fleming JO, et al. Mult Scler. 2011 Jun;17(6):743-54. doi: 10.1177/1352458511398054. Epub 2011 Mar 3. Mult Scler. 2011. PMID: 21372112 Free PMC article. Clinical Trial.

2

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.

Rosche B, Wernecke KD, Ohlraun S, Dörr JM, Paul F. Rosche B, et al. Trials. 2013 Apr 25;14:112. doi: 10.1186/1745-6215-14-112. Trials. 2013. PMID: 23782752 Free PMC article. Clinical Trial.

3

Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial.

Fleming J, Hernandez G, Hartman L, Maksimovic J, Nace S, Lawler B, Risa T, Cook T, Agni R, Reichelderfer M, Luzzio C, Rolak L, Field A, Fabry Z. Fleming J, et al. Mult Scler. 2019 Jan;25(1):81-91. doi: 10.1177/1352458517736377. Epub 2017 Oct 24. Mult Scler. 2019. PMID: 29064315 Free PMC article. Clinical Trial.

4

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.

Voldsgaard A, Bager P, Garde E, Åkeson P, Leffers AM, Madsen CG, Kapel C, Roepstorff A, Thamsborg SM, Melbye M, Siebner H, Søndergaard HB, Sellebjerg F, Sørensen PS. Voldsgaard A, et al. Mult Scler. 2015 Nov;21(13):1723-9. doi: 10.1177/1352458514568173. Epub 2015 Feb 19. Mult Scler. 2015. PMID: 25698173 Clinical Trial.

5

Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients.

Benzel F, Erdur H, Kohler S, Frentsch M, Thiel A, Harms L, Wandinger KP, Rosche B. Benzel F, et al. J Helminthol. 2012 Sep;86(3):339-47. doi: 10.1017/S0022149X11000460. Epub 2011 Aug 15. J Helminthol. 2012. PMID: 21838960 Clinical Trial.

6

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP. Scott LJ, et al. CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.

7

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T. Hurwitz BJ, et al. Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013. Clin Ther. 2008. PMID: 18640466 Clinical Trial.

8

Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer.

Williams AR, Dige A, Rasmussen TK, Hvas CL, Dahlerup JF, Iversen L, Stensvold CR, Agnholt J, Nejsum P. Williams AR, et al. Immunol Lett. 2017 Aug;188:32-37. doi: 10.1016/j.imlet.2017.06.002. Epub 2017 Jun 8. Immunol Lett. 2017. PMID: 28602842

9

The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy.

Yordanova IA, Ebner F, Schulz AR, Steinfelder S, Rosche B, Bolze A, Paul F, Mei HE, Hartmann S. Yordanova IA, et al. Life (Basel). 2021 Jan 29;11(2):101. doi: 10.3390/life11020101. Life (Basel). 2021. PMID: 33572978 Free PMC article.

10

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.

Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D, Holden D, Bianchi L, Adiutori R, MacManus D, Yousry T, Schmierer K, Turner B, Giovannoni G. Gold J, et al. Mult Scler Relat Disord. 2018 Aug;24:123-128. doi: 10.1016/j.msard.2018.06.002. Epub 2018 Jun 28. Mult Scler Relat Disord. 2018. PMID: 29990894 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed